PB2437: ASSOCIATION OF WILMS TUMOR GENE 1 EXPRESSION WITH OVERALL SURVIVAL AFTER AZACYTIDINE AND DONOR LYMPHOCYTE INFUSIONS: A RETROSPECTIVE SINGLE CENTER ANALYSIS

PB2437: ASSOCIATION OF WILMS TUMOR GENE 1 EXPRESSION WITH OVERALL SURVIVAL AFTER AZACYTIDINE AND DONOR LYMPHOCYTE INFUSIONS: A RETROSPECTIVE SINGLE CENTER ANALYSIS

Bibliographic Details
Main Authors:	Semra Aydin, Jennifer Schmitz, Chiara Maria Dellacasa, Irene Dogliotti, Luisa Giaccone, Alessandro Busca
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000976456.87899.bd

Similar Items

2437
by: Deepthi S. Varma, et al.
Published: (2017-09-01)

Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study
by: Mariella Lo Schirico, et al.
Published: (2023-05-01)

Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience
by: Jessica Gill, et al.
Published: (2023-04-01)

Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation
by: Semra Aydin, et al.
Published: (2020-10-01)

TYC 3340-2437-1: A Quadruple System with a Massive Star
by: Jiao Li, et al.
Published: (2024-01-01)

For the study of the manuscript biblical tradition: a new proposal for the analysis of codex 2437
by: Anderson de Oliveira Lima
Published: (2016-06-01)

Donor lymphocyte infusion in bone marrow transplantation therapy
by: Stephen Mackinnon, et al.
Published: (2002-04-01)

Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect
by: Nico Gagelmann, et al.
Published: (2021-04-01)

Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience
by: Alessandro Busca, et al.
Published: (2022-01-01)

Bacterial Bloodstream Infections after Allogeneic Hematopoietic Stem Cell Transplantation: Etiology, Risk Factors and Outcome in a Single-Center Study
by: Jessica Gill, et al.
Published: (2023-03-01)

Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients
by: Nour Shbaklo, et al.
Published: (2023-03-01)

Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis
by: Tomoya Maeda, et al.
Published: (2021-01-01)

Protocolos e práticas de leitura bíblica: o códice 2437 – fólio 151 verso
by: Anderson de Oliveira Lima
Published: (2017-02-01)

PB1998: AZACYTIDINE AND ALLOGENOUS STEM CELL TRANSPLANTATION IN LATE-ONSET ERYTHROPOIETIC PROTOPORPHYRIA
by: Daniel El Fassi, et al.
Published: (2023-08-01)

The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy
by: Katie Maurer, et al.
Published: (2024-03-01)

Antitumor Enhancement by Irradiated Haploidentical Donor Lymphocyte Infusion of Mice with Melanoma
by: Yingjiao Zhu, et al.
Published: (2015-04-01)

5-azacytidine for beta-thalassemia?
by: Clegg, J, et al.
Published: (1983)

Azacytidine Treatment for VEXAS Syndrome
by: Marc H. G. P. Raaijmakers, et al.
Published: (2021-12-01)

Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
by: Shannon R. McCurdy
Published: (2022-06-01)

A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
by: Patrick T. Griffin, et al.
Published: (2016-09-01)

Donor Lymphocyte Infusion and Molecular Monitoring for Relapsed Myelofibrosis After Hematopoietic Cell Transplantation
by: Nico Gagelmann, et al.
Published: (2023-07-01)

Low incidence and morbidity of Epstein‐Barr virus reactivation following donor lymphocyte infusions
by: Danilo Martinovic, et al.
Published: (2023-05-01)

Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients
by: Eugenia Accorsi Buttini, et al.
Published: (2024-03-01)

PB1886: REAL WORLD EXPERIENCE OF VENETOCLAX-AZACYTIDINE COMBINATION IN FRAIL ELDERLY PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY
by: Muhammad Naim Bin Che Rahimi, et al.
Published: (2023-08-01)

Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021
by: Irene Urbino, et al.
Published: (2021-10-01)

Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.
by: Hui Wang, et al.
Published: (2012-01-01)

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells
by: Yong-Rim Kwon, et al.
Published: (2020-09-01)

Comparison of Two Strategies for Prophylactic Donor Lymphocyte Infusion in Patients With Refractory/Relapsed Acute Leukemia
by: Qiongqiong Su, et al.
Published: (2021-03-01)

O códice 2437 do Novo Testamento grego. (Evangelho Grego da Biblioteca Nacional do Rio de Janeiro)
by: Jacyntho Lins Brandão
Published: (2002-01-01)

PB2059: SUCCESSFUL OUTCOME OF A PATIENT WITH ADVANCED SYSTEMIC MASTOCYTOSIS TREATED WITH AZACYTIDINE AND AVAPRITINIB: A CASE REPORT
by: C. Saha, et al.
Published: (2022-06-01)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
by: Panagiotis Diamantopoulos, et al.
Published: (2019-05-01)

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
by: Katrin Teich, et al.
Published: (2023-08-01)

Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis
by: Michael Stadler, et al.
Published: (2022-08-01)

Efficacy of donor lymphocyte infusion in patients after different types of allogeneic hematopoietic stem cell transplantation
by: O A Slesarchuk, et al.
Published: (2013-07-01)

CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms’ tumor
by: Keykhosro Mardanpour, et al.
Published: (2020-12-01)

Suppressing nonsense—a surprising function for 5‐azacytidine
by: Ada Shao, et al.
Published: (2014-12-01)

Cytogenetic effect of 5-azacytidine in patients with hematological malignancies
by: Jessica Romy Tsuda, et al.
Published: (2011-10-01)

Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis
by: Semra Aydin, et al.
Published: (2023-02-01)

Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after bone marrow transplantation
by: Castro F.A., et al.
Published: (2004-01-01)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
by: Carmine Liberatore, et al.
Published: (2022-06-01)